Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422

Watchlist Manager
Sichuan Kelun Pharmaceutical Co Ltd Logo
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Watchlist
Price: 30.6 CNY -7.66% Market Closed
Market Cap: 46.9B CNY
Have any thoughts about
Sichuan Kelun Pharmaceutical Co Ltd?
Write Note

Sichuan Kelun Pharmaceutical Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sichuan Kelun Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
47%
CAGR 5-Years
22%
CAGR 10-Years
12%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Income from Continuing Operations
ÂĄ3B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Income from Continuing Operations
ÂĄ5.4B
CAGR 3-Years
-5%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Income from Continuing Operations
ÂĄ4.5B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Income from Continuing Operations
-ÂĄ780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sichuan Kelun Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
3.3B CNY

Based on the financial report for Jun 30, 2024, Sichuan Kelun Pharmaceutical Co Ltd's Income from Continuing Operations amounts to 3.3B CNY.

What is Sichuan Kelun Pharmaceutical Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
12%

Over the last year, the Income from Continuing Operations growth was 37%. The average annual Income from Continuing Operations growth rates for Sichuan Kelun Pharmaceutical Co Ltd have been 47% over the past three years , 22% over the past five years , and 12% over the past ten years .

Back to Top